BLC
Brown, Lisle/Cummings Portfolio holdings
AUM
$376M
This Quarter Return
-2.39%
1 Year Return
+15.36%
3 Year Return
+61.8%
5 Year Return
–
10 Year Return
–
AUM
$221M
AUM Growth
+$221M
(-1.1%)
Cap. Flow
+$6.32M
Cap. Flow
% of AUM
2.86%
Top 10 Holdings %
Top 10 Hldgs %
27.92%
Holding
569
New
13
Increased
111
Reduced
70
Closed
19
Top Buys
| 1 |
Novo Nordisk
NVO
|
$1.86M |
| 2 |
Canadian National Railway
CNI
|
$355K |
| 3 |
T Rowe Price
TROW
|
$307K |
| 4 |
CF Industries
CF
|
$279K |
| 5 |
Pfizer
PFE
|
$263K |
Top Sells
| 1 |
W.P. Carey
WPC
|
$646K |
| 2 |
Simon Property Group
SPG
|
$184K |
| 3 |
Apple
AAPL
|
$170K |
| 4 |
Bristol-Myers Squibb
BMY
|
$158K |
| 5 |
DXC Technology
DXC
|
$128K |
Sector Composition
| 1 | Healthcare | 18.81% |
| 2 | Technology | 15.35% |
| 3 | Financials | 13.51% |
| 4 | Industrials | 8.79% |
| 5 | Communication Services | 6.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
SPDR S&P 500 ETF Trust
SPY
$650B
| $11.4M | 5.17% |
26,749
-25
| -0.1% | -$10.7K |
|
|
2
Apple
AAPL
$3.39T
| $6.96M | 3.15% |
40,668
-992
| -2% | -$170K |
|
3
Accenture
ACN
$158B
| $6.51M | 2.95% |
21,201
+495
| +2% | +$152K |
|
4
Microsoft
MSFT
$3.73T
| $6.42M | 2.9% |
20,325
+90
| +0.4% | +$28.4K |
|
5
Intercontinental Exchange
ICE
$100B
| $5.92M | 2.68% |
53,850
+1,700
| +3% | +$187K |
|
6
Amgen
AMGN
$154B
| $5.92M | 2.68% |
22,012
+710
| +3% | +$191K |
|
7
Alphabet (Google) Class A
GOOGL
$2.51T
| $5.85M | 2.65% |
44,730
+455
| +1% | +$59.5K |
|
8
Amazon
AMZN
$2.39T
| $4.66M | 2.11% |
36,645
-110
| -0.3% | -$14K |
|
9
Veeva Systems
VEEV
$43.9B
| $4.03M | 1.83% |
19,828
+10
| +0.1% | +$2.04K |
|
|
10
Canadian National Railway
CNI
$60.2B
| $4M | 1.81% |
36,943
+3,275
| +10% | +$355K |
|
11
iShares Short-Term National Muni Bond ETF
SUB
$10.2B
| $3.83M | 1.73% |
37,237
| – | – |
|
12
Boston Scientific
BSX
$157B
| $3.81M | 1.73% |
72,217
+2,525
| +4% | +$133K |
|
13
Berkshire Hathaway Class B
BRK.B
$1.08T
| $3.46M | 1.57% |
9,885
-5
| -0.1% | -$1.75K |
|
|
14
T Rowe Price
TROW
$23.1B
| $3.44M | 1.56% |
32,825
+2,925
| +10% | +$307K |
|
|
15
Novo Nordisk
NVO
$249B
| $3.39M | 1.53% |
37,290
+20,495
| +122% | +$1.86M |
|
|
16
Alphabet (Google) Class C
GOOG
$2.52T
| $3.31M | 1.5% |
25,077
+1,240
| +5% | +$163K |
|
17
AbbVie
ABBV
$373B
| $3.2M | 1.45% |
21,492
+425
| +2% | +$63.4K |
|
18
JPMorgan Chase
JPM
$818B
| $3.14M | 1.42% |
21,627
-110
| -0.5% | -$16K |
|
19
Fiserv
FI
$73.7B
| $3M | 1.36% |
26,565
+315
| +1% | +$35.6K |
|
20
Thermo Fisher Scientific
TMO
$182B
| $2.97M | 1.35% |
5,877
+144
| +3% | +$72.9K |
|
21
Blackstone
BX
$131B
| $2.65M | 1.2% |
24,756
+2,400
| +11% | +$257K |
|
|
22
W.P. Carey
WPC
$14.5B
| $2.44M | 1.11% |
45,171
-11,949
| -21% | -$646K |
|
23
Marsh & McLennan
MMC
$101B
| $2.31M | 1.04% |
12,134
-99
| -0.8% | -$18.8K |
|
24
Meta Platforms (Facebook)
META
$1.84T
| $2.21M | 1% |
7,360
+400
| +6% | +$120K |
|
25
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$13.7B
| $2.13M | 0.96% |
21,258
-543
| -2% | -$54.4K |
|